AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Dividends paid: -$1M in Q2 2026, down 90.0% from a year earlier.
Latest, Q2 2026
-1
Period ended Jun 30, 2026
Change on a year earlier
-90.0%
-10 in Q2 2025
History
22 quarters
Since Q1 2021
Sources
22
Documents cited below
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 6-K FY2026Q2 Earnings Release ↗
Reported in Consolidated Statement of Cash Flows (Postgres DB).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AstraZeneca Dividends paid ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin-div-db
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.